Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’
Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Novo Nordisk’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis
Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, observational data showed.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
4h
Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...
AZ Central
1d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Lucrative weight loss drugs are new focus for diabetes patients The insulin supply shortages come as diabetes patients ...
plantbasednews
4h
BREAKING: Dr Greger Examines Why Plant-Based Diets Are Better Than Ozempic In New Book
Renowned plant-based physician Dr. Michael Greger has released a new book on the risks, benefits, and alternatives to Ozempic ...
The Economist
1d
It’s not just obesity. Drugs like Ozempic will change the world
First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...
3h
One Type of Fiber May Have Weight Loss Benefits Similar to Ozempic
Some fibers, like oat beta-glucans and wheat dextrin, are water- soluble, meaning they are easily fermented by gut bacteria.
18h
on MSN
Can Eating More Protein Be A Natural Alternative To Ozempic? A Dietitian Explains
To add more protein to your life, you can consider adding animal proteins like eggs, cottage cheese, Greek yogurt, and ...
1d
on MSN
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...
1d
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Alzheimer's disease
Wegovy
Weight loss
Novo Nordisk
Christina Aguilera
Feedback